JeffreyPaulLetzerDO

Hematology • Fort Wayne, IN

Hematologic Oncology

Parkview Cancer Institute

Join to view full profile

Dr. Letzer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Letzer's full profile

Already have an account?

Office
11109 Parkview Plaza Drive
Fort Wayne, IN 46845
Phone+1 260-266-7100

Fax+1 260-266-7634
Is this information wrong?

Summary

Dr. Jeffrey Letzer is a hematologist in Fort Wayne, IN, and is affiliated with Parkview Regional Medical Center.

Education & Training

Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1993
Rush University Medical CenterFellowship, Hematology and Medical Oncology, 1990 - 1991
Michigan State University College of Osteopathic MedicineClass of 1986

Certifications & Licensure

IN State License 2019 - 2025
MI State License 1987 - 2025
OH State License 1988 - 1994
IL State License 1990 - 1993
AOA Board of Internal Medicine Hematology
AOA Board of Internal Medicine Internal Medicine
AOA Board of Internal Medicine Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013

Clinical Trials

Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma
No longer available

Publications & Presentations

PubMed

87 citations
Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study
Nathan Fowler, Brad S. Kahl, Peter P. Lee, Jeffrey Matous, Amanda F. Cashen, Samuel A. Jacobs, Jeffrey Letzer, Bipinkumar Amin, Michael E. Williams, Sonali M. Smith, A...> ;Journal of Clinical Oncology. 2011 Sep 1
Randomized phase II study of perifosine in combination with capecitabine versus capecitabine alone in patients with second- or third-line metastatic colon cancer.
Vukelja S, Richards D, Campos LT, Bedell C, Hagenstad C, Hyman W, Letzer J, Gardner L, Sportelli P, Nemunaitis J> ;J. Clin. Oncol.. 2009-05-20
Bortezomib, bendamustine, and rituximab in patients (pts) with relapsed (rel) or refractory (ref) follicular lymphoma (FL): Dose-finding results of the VERTICAL study.
Matous J, Letzer J, Rosen P, Noga S, Fowler N, Smith S, Amin B, Shi H, Parasuraman S, Cheson B> ;J. Clin. Oncol.. 2009-05-20
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin''s lymphoma.
Tulpule, A., Rarick, M. U., Kolitz, J., Bernstein, J., Myers, A., Buchanan, L. A., Espina, B. M., Traynor, A., Letzer, J., Justice, G. R., McDonald, D., Roberts, L., B...> ;Ann Oncol. 2001 Apr
Join now to see all

Professional Memberships

American Osteopathic Association - AOA
Member
American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member

Hospital Affiliations

Parkview Regional Medical CenterFort Wayne, Indiana
ProMedica Coldwater Regional HospitalColdwater, Michigan